4. GE Healthcare (General Electric)
Chicago
2018 revenue: $19,784,000,000
Fiscal year ending: Dec. 31, 2018
Last year’s rank: 5
Key Personnel:
Kieran Murphy, president & CEO; Monish Patolawala, CFO; Katya Kruglova, VP, HR; James Borzi, VP, chief supply chain officer; Michael McAlevey, VP, GC & business development; Ehren Powell, CIO; Thomas Westrick VP & CQO; Greg Gibbons, chief communications officer; Amit Phadnis, chief digital officer; Terri Bresenham, chief innovation officer; Tom McGuinness, president & CEO, imaging; Anders Wold, president & CEO, clinical care solutions; Emmanuel Ligner, president & CEO, life sciences; Kevin O’Neill, president & CEO, pharmaceutical diagnostics; Jan Makela, president & CEO, global services; Laurent Dubois, CEO healthcare partners
Description:
GE Healthcare (NYSE:GE) still wound up under the umbrella of troubled parent General Electric after a tumultuous year. GE announced in June 2018 that it was looking to sell off a 20% stake and by January was said to be eyeing an even bigger carveout, of as much as 49.9%. But in February new CEO Larry Culp, the former Danaher chief hired in October 2018 to engineer a turnaround, tabled the healthcare spinout so the industrial conglomerate could focus on the $21 billion sale of its biopharmaceuticals business. In June of this year GE was said to be shopping its venture capital portfolio of more than 100 startups across the healthcare, tech and energy sectors, looking to rein in its $110 billion debt load. GE Healthcare logged full-year profit growth of 6.0% to $3.70 billion on sales growth of 4.0% to $19.78 billion, while its parent’s full-year losses rose 155.6% to -$22.80 billion on sales growth of 2.3% to $113.54 billion. –BP